APA (7th ed.) Citation

Liu, S., Hu, Q., Xie, Z., Chen, S., Li, Y., Quan, N., . . . Fang, L. (2023). An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma. Journal of cancer research and clinical oncology, 149(17), 15589-15608. https://doi.org/10.1007/s00432-023-05312-x

Chicago Style (17th ed.) Citation

Liu, Shuguang, Qianying Hu, Zishan Xie, Shaojing Chen, Yixuan Li, Nali Quan, Kaimeng Huang, Riqing Li, and Lishan Fang. "An Endoplasmic Reticulum Stress-related Signature Could Robustly Predict Prognosis and Closely Associate with Response to Immunotherapy in Pancreatic Ductal Adenocarcinoma." Journal of Cancer Research and Clinical Oncology 149, no. 17 (2023): 15589-15608. https://doi.org/10.1007/s00432-023-05312-x.

MLA (9th ed.) Citation

Liu, Shuguang, et al. "An Endoplasmic Reticulum Stress-related Signature Could Robustly Predict Prognosis and Closely Associate with Response to Immunotherapy in Pancreatic Ductal Adenocarcinoma." Journal of Cancer Research and Clinical Oncology, vol. 149, no. 17, 2023, pp. 15589-15608, https://doi.org/10.1007/s00432-023-05312-x.